UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression

Stroud, JB; Freeman, TP; Leech, R; Hindocha, C; Lawn, W; Nutt, DJ; Curran, HV; (2018) Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression. Psychopharmacology , 235 (2) pp. 459-466. 10.1007/s00213-017-4754-y. Green open access

[thumbnail of Stroud2018_revArticle_PsilocybinWithPsychologicalSup.pdf]
Preview
Text
Stroud2018_revArticle_PsilocybinWithPsychologicalSup.pdf

Download (604kB) | Preview

Abstract

RATIONALE: Depressed patients robustly exhibit affective biases in emotional processing which are altered by SSRIs and predict clinical outcome. OBJECTIVES: The objective of this study is to investigate whether psilocybin, recently shown to rapidly improve mood in treatment-resistant depression (TRD), alters patients' emotional processing biases. METHODS: Seventeen patients with treatment-resistant depression completed a dynamic emotional face recognition task at baseline and 1 month later after two doses of psilocybin with psychological support. Sixteen controls completed the emotional recognition task over the same time frame but did not receive psilocybin. RESULTS: We found evidence for a group × time interaction on speed of emotion recognition (p = .035). At baseline, patients were slower at recognising facial emotions compared with controls (p < .001). After psilocybin, this difference was remediated (p = .208). Emotion recognition was faster at follow-up compared with baseline in patients (p = .004, d = .876) but not controls (p = .263, d = .302). In patients, this change was significantly correlated with a reduction in anhedonia over the same time period (r = .640, p = .010). CONCLUSIONS: Psilocybin with psychological support appears to improve processing of emotional faces in treatment-resistant depression, and this correlates with reduced anhedonia. Placebo-controlled studies are warranted to follow up these preliminary findings.

Type: Article
Title: Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression
Location: Germany
Open access status: An open access version is available from UCL Discovery
DOI: 10.1007/s00213-017-4754-y
Publisher version: http://doi.org/10.1007/s00213-017-4754-y
Language: English
Additional information: © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License http://creativecommons.org/ licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Keywords: Anhedonia, Emotional face recognition, Psilocybin, Treatment-resistant depression
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Div of Psychology and Lang Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Div of Psychology and Lang Sciences > Clinical, Edu and Hlth Psychology
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10034334
Downloads since deposit
8,162Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item